Does METRELEPTIN Cause Therapy cessation? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Therapy cessation have been filed in association with METRELEPTIN (Myalept). This represents 8.3% of all adverse event reports for METRELEPTIN.
94
Reports of Therapy cessation with METRELEPTIN
8.3%
of all METRELEPTIN reports
7
Deaths
42
Hospitalizations
How Dangerous Is Therapy cessation From METRELEPTIN?
Of the 94 reports, 7 (7.4%) resulted in death, 42 (44.7%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRELEPTIN. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does METRELEPTIN Cause?
Product dose omission issue (88)
Weight decreased (88)
Blood glucose increased (77)
Drug ineffective (69)
Therapy interrupted (65)
Nausea (57)
Off label use (51)
Blood triglycerides increased (49)
Treatment noncompliance (49)
Weight increased (45)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which METRELEPTIN Alternatives Have Lower Therapy cessation Risk?
METRELEPTIN vs METRONIDAZOLE
METRELEPTIN vs METRONIDAZOLE\METRONIDAZOLE
METRELEPTIN vs METYRAPONE
METRELEPTIN vs MEXILETINE
METRELEPTIN vs MIANSERIN